Status:
COMPLETED
Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
French Society of Rheumatology
Conditions:
Rheumatoid Arthritis
Spondyloarthritis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The hypothesis is that group interaction associated with individual interviews intensify the acquisition of safety skills compared to individual interviews alone in patients with CIR treated by subcut...
Detailed Description
Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signatur...
Eligibility Criteria
Inclusion
- Patient age \> 18 years old with RA (ACR/EULAR criteria) or SA (ASAS criteria) initiating a first subcutaneous biotherapy.
- Patient able to complete a questionnaire
- Patient giving informed consent.
- Patient covered by social security
Exclusion
- \- Patient with disorder of higher mental function or psychiatric disorders.
- Patient previously treated by intravenous biotherapy.
- Protected populations: pregnant women, breastfeeding women, tutorship, trusteeship, deprived of liberty, safeguard of justice.
Key Trial Info
Start Date :
January 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03838939
Start Date
January 21 2019
End Date
December 10 2021
Last Update
December 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont-Ferrand
Clermont-Ferrand, France, 63003